Stocks
Health Care
cgon
Cg Oncology
CGON
+1.30 (+4.97%)
27.375
USD
At close at Jul 17, 17:47 UTC
Overview
Loading chart...
Key Stats
Market Cap
1.99B
Dividend Yield
0.00%
P/E Ratio
-18.83
EPS
-1.50
Revenue
662.00K
Avg. Volume
2.99M
Recently from Cashu
No Cashu articles
Cg Oncology currently has no Cashu-related articles
About
What does CGON do?
CG Oncology, based in Irvine, California, focuses on developing bladder-sparing therapies for bladder cancer and went public on January 25, 2024. Its key candidates include cretostimogene and BOND-003, both targeting non-muscle invasive bladder cancer.
Join our newsletter to keep up to date with us!
